Goldman Sachs’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Buy |
220,600
+73,272
| +50% | +$3.56M | ﹤0.01% | 2225 |
|
|
2025
Q1 | $5.01M | Sell |
147,328
-49,946
| -25% | -$1.7M | ﹤0.01% | 2740 |
|
|
2024
Q4 | $7.76M | Sell |
197,274
-12,566
| -6% | -$495K | ﹤0.01% | 2519 |
|
|
2024
Q3 | $9.86M | Sell |
209,840
-55,507
| -21% | -$2.61M | ﹤0.01% | 2277 |
|
|
2024
Q2 | $14.3M | Buy |
265,347
+132,650
| +100% | +$7.16M | ﹤0.01% | 1821 |
|
|
2024
Q1 | $9.04M | Sell |
132,697
-54,923
| -29% | -$3.74M | ﹤0.01% | 2128 |
|
|
2023
Q4 | $11.7M | Buy |
187,620
+63,575
| +51% | +$3.98M | ﹤0.01% | 1953 |
|
|
2023
Q3 | $5.63M | Sell |
124,045
-13,440
| -10% | -$610K | ﹤0.01% | 2383 |
|
|
2023
Q2 | $7.72M | Sell |
137,485
-99,969
| -42% | -$5.61M | ﹤0.01% | 2240 |
|
|
2023
Q1 | $10.7M | Sell |
237,454
-259,779
| -52% | -$11.7M | ﹤0.01% | 1958 |
|
|
2022
Q4 | $20.2M | Sell |
497,233
-248,673
| -33% | -$10.1M | 0.01% | 1612 |
|
|
2022
Q3 | $48.7M | Buy |
745,906
+250,700
| +51% | +$16.4M | 0.01% | 989 |
|
|
2022
Q2 | $30.1M | Buy |
495,206
+378,609
| +325% | +$23M | 0.01% | 1322 |
|
|
2022
Q1 | $7.32M | Sell |
116,597
-37,589
| -24% | -$2.36M | ﹤0.01% | 2497 |
|
|
2021
Q4 | $11.7M | Sell |
154,186
-173,896
| -53% | -$13.2M | ﹤0.01% | 2154 |
|
|
2021
Q3 | $36.7M | Buy |
328,082
+251,401
| +328% | +$28.1M | 0.01% | 1298 |
|
|
2021
Q2 | $12.4M | Sell |
76,681
-23,692
| -24% | -$3.84M | ﹤0.01% | 2094 |
|
|
2021
Q1 | $12.2M | Sell |
100,373
-15,617
| -13% | -$1.9M | ﹤0.01% | 2056 |
|
|
2020
Q4 | $17.8M | Buy |
115,990
+39,063
| +51% | +$5.98M | ﹤0.01% | 1645 |
|
|
2020
Q3 | $6.43M | Sell |
76,927
-33,131
| -30% | -$2.77M | ﹤0.01% | 2236 |
|
|
2020
Q2 | $8.09M | Buy |
110,058
+5,657
| +5% | +$416K | ﹤0.01% | 2062 |
|
|
2020
Q1 | $4.43M | Sell |
104,401
-25,561
| -20% | -$1.08M | ﹤0.01% | 2319 |
|
|
2019
Q4 | $7.92M | Buy |
129,962
+73,934
| +132% | +$4.5M | ﹤0.01% | 2164 |
|
|
2019
Q3 | $2.3M | Buy |
56,028
+5,175
| +10% | +$212K | ﹤0.01% | 2758 |
|
|
2019
Q2 | $2.4M | Buy |
50,853
+9,388
| +23% | +$442K | ﹤0.01% | 2710 |
|
|
2019
Q1 | $1.48M | Sell |
41,465
-10,214
| -20% | -$365K | ﹤0.01% | 3082 |
|
|
2018
Q4 | $1.48M | Buy |
51,679
+2,029
| +4% | +$58K | ﹤0.01% | 2943 |
|
|
2018
Q3 | $2.2M | Sell |
49,650
-2,428
| -5% | -$108K | ﹤0.01% | 2829 |
|
|
2018
Q2 | $3.06M | Buy |
52,078
+24,516
| +89% | +$1.44M | ﹤0.01% | 2666 |
|
|
2018
Q1 | $1.26M | Buy |
27,562
+4,890
| +22% | +$224K | ﹤0.01% | 3091 |
|
|
2017
Q4 | $532K | Buy |
+22,672
| New | +$532K | ﹤0.01% | 3420 |
|